drugset / Trial / NCT00037661

Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye

NCT00037661

Phase 3 Completed 222 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

Comparative efficacy trial of INS365 Ophthalmic Solution and placebo in patients with dry eye.

Timeline

Start
2002-04
Primary completion
2003-03
Completion
2003-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Diquafosol tetrasodium Oligonucleotide (other)

Indications